
Bristol-Myers Squibb Co
NYSE:BMY

Wall Street
Price Targets
BMY Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for
BMY
is 60.92 USD
with a low forecast of 33.43 USD and a high forecast of 73.5 USD.
Operating Income
Forecast
Operating Income Estimate
Bristol-Myers Squibb Co
For the last 8 years the
compound annual growth rate for
Bristol-Myers Squibb Co's operating income is
10%.
The projected
CAGR
for the next 3 years is
11%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BMY's stock price target?
Price Target
60.92
USD
According to Wall Street analysts, the average 1-year price target for
BMY
is 60.92 USD
with a low forecast of 33.43 USD and a high forecast of 73.5 USD.
What is Bristol-Myers Squibb Co's Revenue forecast?
Projected CAGR
-4%
For the last 8 years the
compound annual growth rate for
Bristol-Myers Squibb Co's revenue is
12%.
The projected
CAGR
for the next 3 years is
-4%.
What is Bristol-Myers Squibb Co's Operating Income forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
Bristol-Myers Squibb Co's operating income is
10%.
The projected
CAGR
for the next 3 years is
11%.